AlphaYou
Overview
Smart money at a glance
Filings to Sep 25, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 7 added, 4 cutMore adding
Key stats
Fundamentals Sep 25- Open
- $85.83
- 52-wk high
- $110.00
- High
- $86.01
- 52-wk low
- $68.48
- Low
- $84.50
- Prev close
- $85.05
- Mkt cap
- $108.78B
- P/E
- 22.7x
- Volume
- 7.38M
- Fwd P/E
- 10.7x
- Beta
- 0.58
- Div yield
- 3.10%
- P/S
- 0.3x
- P/B
- 1.4x
- Profit margin
- +1.2%
- Op margin
- +3.9%
- ROE
- +6.2%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CVS filings
Are insiders buying or selling CVS Health Corp (CVS) stock?
Neither. CVS Health Corp (CVS) insiders filed no open-market purchases or sales in the 90 days to Sep 25, 2026, according to SEC Form 4 filings.
Which members of Congress have traded CVS recently?
None. No member of Congress disclosed a CVS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CVS smart-money data?
This summary uses filings available on Sep 25, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- VG
Viking Global
$379.0M
bought
- MI
Millennium
$210.0M
added
- BO
Bank of America
$1.7B
added
What insiders are doing
Sells (2)
- RL
Robbins Larry
$317.5M
sold
- MT
Mandadi Tilak
$6.2M
sold
What Congress is doing
Buys (1)
Sells (1)
How top traders are positioned
No tracked top-trader positions in CVS right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 38.0% above what analysts expected.
Earnings per share
$1.87 expected
GAAP EPS was $2.31 and adjusted EPS was $2.58. The analyst basis could not be confirmed, so no beat or miss is shown.
Reports Nov 4, 2026, in 40 days
EPS expected
$1.46 to $1.80
Revenue expected
17 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $102.87B | $105.69B | $100.43B | $106.10B |
| Cost of what it sold | $89.06B | $92.13B | $84.80B | $90.35B |
| Gross profit | $13.81B | $13.57B | $15.62B | $15.75B |
| What it spent | ||||
| Other operating costs | $17.01B | $11.46B | $10.94B | $11.05B |
| Total operating expenses | $17.01B | $11.46B | $10.94B | $11.05B |
| What was left | ||||
| Operating profit | -$3.21B | $2.11B | $4.68B | $4.70B |
| Interest on debt | $784.0M | $787.0M | $774.0M | $757.0M |
| Profit before tax | -$3.48B | $1.35B | $3.94B | $3.98B |
| Tax | $508.0M | -$1.57B | $995.0M | $982.0M |
| Net profit | -$3.98B | $2.94B | $2.94B | $3.00B |
| EBITDA | -$1.56B | $3.29B | $5.83B | $5.86B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Did UnitedHealth Name The Fix Before Its Stock Ran?
NeutralSep 23Measles can infect up to 9 in 10 unprotected people nearby. CVS offers Tennessee shots.
BullishSep 23CVS settles data privacy lawsuit for $20.5M: See if you qualify for a payout
Leans bearishSep 23CVS Health strengthens energy resilience to support patient care
BullishSep 23CVS Health stock holds near USD 87.73 as earnings beat estimates
BullishSep 23CVS settles data privacy lawsuit for $20.5M: See if you qualify for a payout
Leans bearishSep 23Can execution catch up with expectations at Caterpillar (NYSE:CAT)?
NeutralSep 23Can Coca-Cola (NYSE:KO) turn global beverage demand and pricing discipline into a stronger market story?
NeutralSep 23